🇺🇸 FDA
Patent

US 10100083

Leukemia stem cell targeting ligands and methods of use

granted A61KA61K47/62A61K47/6907

Quick answer

US patent 10100083 (Leukemia stem cell targeting ligands and methods of use) held by The Regents of the University of California expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K47/62, A61K47/6907, A61K51/08, A61P